Xoma conducts reverse split; drug indexes slip

Shares of biotech group Xoma Ltd. spike over 1,000% at the market open, as the company conducts a 1-for-15 reverse stock split in order to boost its stock price to meet Nasdaq compliance rules.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.